Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers

NCT01043094 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Renal Impairment

Interventions

DRUG: Pitavastatin 4mg

Sponsor

Kowa Research Institute, Inc.